Connexin43 interacts with βarrestin: A pre-requisite for osteoblast survival induced by parathyroid hormone

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2920-2930

  Bivi, Nicoletta ^a   Lezcano, Virginia ^b   Romanello, Milena ^c   Bellido, Teresita ^a   Plotkin, Lilian I ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

arrestin; Cx43; osteoblast survival; PTH

Indexed keywords

BETA ARRESTIN; CONNEXIN 43; PARATHYROID HORMONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; ARRESTINS; BLOTTING, WESTERN; CELL LINE; CONNEXIN 43; IMMUNOPRECIPITATION; MICE; MICROSCOPY, CONFOCAL; OSTEOBLASTS; PARATHYROID HORMONE; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80053047894     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23208     Document Type: Article

References (60)

1. Ai X, Pogwizd SM,. 2005. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type2A. Circ Res 96: 54-63. (Pubitemid 40095754)
2. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ,. 1992. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267: 17882-17890.
3. Bao X, Reuss L, Altenberg GA,. 2004. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of Serine 368. J Biol Chem 279: 20058-20066. (Pubitemid 38623450)
4. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL,. 2003. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278: 50259-50272. (Pubitemid 37548867)
5. Beyer EC, Paul DL, Goodenough DA,. 1990. Connexin family of gap junction proteins. J Membr Biol 116: 187-194. (Pubitemid 20222697)
6. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E,. 2001. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107: 277-286. (Pubitemid 32157960)
7. Calvo N, de Boland AR, Gentili C,. 2010. PTH inactivates the AKT survival pathway in the colonic cell line Caco-2. Biochim Biophys Acta 1803: 343-351.
8. Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M, Lohse MJ,. 2002. Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and βarrestins. Endocrinology 143: 3854-3865. (Pubitemid 35244365)
9. Chung D, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R,. 2006. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci 119: 4187-4198. (Pubitemid 44774025)
10. Civitelli R,. 2008. Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys 473: 188-192.
11. Civitelli R, Ziambaras K, Warlow PM, Lecanda F, Nelson T, Harley J, Atal N, Beyer EC, Steinberg TH,. 1998. Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 68: 8-21.
12. Crespin S, Bechberger J, Mesnil M, Naus CC, Sin WC,. 2010. The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells. J Cell Biochem 110: 589-597.
13. Dang X, Doble BW, Kardami E,. 2003. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 242: 35-38. (Pubitemid 36240526)
14. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW,. 2000a. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97: 11086-11091.
15. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW,. 2000b. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281.
16. Duthe F, Plaisance I, Sarrouilhe D, Herve JC,. 2001. Endogenous protein phosphatase 1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol Cell Physiol 281: C1648-C1656.
17. Ferrari SL, Bisello A,. 2001. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by beta-arrestin2. Mol Endocrinol 15: 149-163. (Pubitemid 32156048)
18. Ferrari SL, Behar V, Chorev M, Rosenblatt M, Bisello A,. 1999. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem 274: 29968-29975.
19. Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, Bouxsein ML,. 2005. Bone response to intermittent parathyroid hormone is altered in mice null for beta-Arrestin2. Endocrinology 146: 1854-1862. (Pubitemid 40396895)
20. Ge L, Ly Y, Hollenberg MD, DeFea K,. 2003. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2 induced chemotaxis. J Biol Chem 278: 34418-34426. (Pubitemid 37553288)
21. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Loomis CR, Spurney RF, Luttrell LM, Lefkowitz RJ,. 2006. Distinct beta-arrestin and G protein dependent pathways for parathyroid hormone receptor stimulated ERK1/2 activation. J Biol Chem 281: 10856-10864. (Pubitemid 43855508)
22. Giepmans BN,. 2004. Gap junctions and connexin-interacting proteins. Cardiovasc Res 62: 233-245. (Pubitemid 38496537)
23. Goodenough DA, Paul DL,. 2003. Beyond the gap: Functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4: 285-294. (Pubitemid 36383955)
24. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK,. 2005. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 26: 688-703. (Pubitemid 41127277)
25. Jilka RL,. 2007. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40: 1434-1446. (Pubitemid 46756429)
26. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC,. 1999. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104: 439-446. (Pubitemid 29534328)
27. Keyel PA, Thieman JR, Roth R, Erkan E, Everett ET, Watkins SC, Heuser JE, Traub LM,. 2008. The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis. Mol Biol Cell 19: 5309-5326.
28. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, Di Gregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC,. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104: 719-730. (Pubitemid 32241022)
29. Krutovskikh VA, Yamasaki H, Tsuda H, Asamoto M,. 1998. Inhibition of intrinsic gap-junction intercellular communication and enhancement of tumorigenicity of the rat bladder carcinoma cell line BC31 by a dominant-negative connexin 43 mutant. Mol Carcinog 23: 254-261. (Pubitemid 29035259)
30. Lampe PD, Lau AF,. 2000. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384: 205-215. (Pubitemid 32012794)
31. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF,. 2000. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 149: 1503-1512. (Pubitemid 30437622)
32. Lecanda F, Towler DA, Ziambaras K, Cheng SL, Koval M, Steinberg TH, Civitelli R,. 1998. Gap junctional communication modulates gene expression in osteoblastic cells. Mol Biol Cell 9: 2249-2258. (Pubitemid 28373637)
33. Lecka-Czernik B, Gubrij I, Moerman EA, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL,. 1999. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma 2. J Cell Biochem 74: 357-371. (Pubitemid 29344887)
34. Liang JY, Wang SM, Chung TH, Yang SH, Wu JC,. 2008. Effects of 18-glycyrrhetinic acid on serine 368 phosphorylation of connexin43 in rat neonatal cardiomyocytes. Cell Biol Int 32: 1371-1379.
35. -ΔΔCT method. Methods 25: 402-408. (Pubitemid 34164012)
36. Martin TJ,. 2005. Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115: 2322-2324. (Pubitemid 41266192)
37. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC,. 2005. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH1-34. J Clin Invest 115: 2402-2411. (Pubitemid 41266202)
38. Miura T, Yano T, Naitoh K, Nishihara M, Miki T, Tanno M, Shimamoto K,. 2007. Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43. Am J Physiol Heart Circ Physiol 293: H1425-H1431. (Pubitemid 47367185)
39. O'Brien CA, Plotkin LI, Galli C, Goellner J, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T,. 2008. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS ONE 3: e2942.
40. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T,. 1999. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104: 1363-1374.
41. Plotkin LI, Manolagas SC, Bellido T,. 2002. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 277: 8648-8657. (Pubitemid 34968331)
42. Plotkin LI, Aguirre JI, Kousteni S, Manolagas SC, Bellido T,. 2005. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation. J Biol Chem 280: 7317-7325. (Pubitemid 40341290)
43. Plotkin LI, Vyas K, Gortazar AR, Manolagas SC, Bellido T,. 2006. βarrestin complexes with connexin (Cx) 43 and anchors ERKs outside the nucleus: A requirement for the Cx43/ERK-mediated anti-apoptotic effect of bisphosphonates in osteocytes. J Bone Miner Res 21: S65.
44. Plotkin LI, Lezcano V, Thostenson J, Weinstein RS, Manolagas SC, Bellido T,. 2008. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res 23: 1712-1721.
45. Premont RT, Gainetdinov RR,. 2007. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69: 511-534. (Pubitemid 46457653)
46. Richards TS, Dunn CA, Carter WG, Usui ML, Olerud JE, Lampe PD,. 2004. Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368. J Cell Biol 167: 555-562. (Pubitemid 39489062)
47. Roscoe W, Veitch GI, Gong XQ, Pellegrino E, Bai D, McLachlan E, Shao Q, Kidder GM, Laird DW,. 2005. Oculodentodigital dysplasia-causing connexin43 mutants are non-functional and exhibit dominant effects on wild-type connexin43. J Biol Chem 280: 11458-11466. (Pubitemid 40418455)
48. Sin WC, Tse M, Planque N, Perbal B, Lampe PD, Naus CC,. 2009. Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization. J Biol Chem 284: 29935-29944.
49. Sneddon WB, Friedman PA,. 2007. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization. Endocrinology 148: 4073-4079. (Pubitemid 47105863)
50. Solan JL, Lampe PD,. 2009. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 419: 261-272.
51. Steinberg TH, Civitelli R, Geist ST, Robertson AJ, Hick E, Veenstra RD, Wang HZ, Warlow PM, Westphale EM, Laing JG,. 1994. Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells. EMBO J 13: 744-750. (Pubitemid 24057504)
52. Syme CA, Friedman PA, Bisello A,. 2005. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J Biol Chem 280: 11281-11288. (Pubitemid 40418434)
53. Tetradis S, Bezouglaia O, Tsingotjidou A, Vila A,. 2001. Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem Biophys Res Commun 281: 913-916. (Pubitemid 32917817)
54. Tong D, Li TY, Naus KE, Bai D, Kidder GM,. 2007. In vivo analysis of undocked connexin43 gap junction hemichannels in ovarian granulosa cells. J Cell Sci 120: 4016-4024. (Pubitemid 350269407)
55. Valiunas V, Gemel J, Brink PR, Beyer EC,. 2001. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 281: H1675-H1689.
56. Vander Molen MA, Rubin CT, McLeod KJ, McCauley LK, Donahue HJ,. 1996. Gap junctional intercellular communication contributes to hormonal responsiveness in osteoblastic networks. J Biol Chem 271: 12165-12171. (Pubitemid 26160874)
57. Vilardaga JP, Frank M, Krasel C, Dees C, Nissenson RA, Lohse MJ,. 2001. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein. J Biol Chem 276: 33435-33443.
58. Wang B, Yang Y, Abou-Samra AB, Friedman PA,. 2009. NHERF1 regulates parathyroid hormone receptor desensitization: Interference with beta-arrestin binding. Mol Pharmacol 75: 1189-1197.
59. Yogo K, Ogawa T, Akiyama M, Ishida N, Takeya T,. 2002. Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells. FEBS Lett 531: 132-136. (Pubitemid 35341183)
60. Zhou L, Kasperek EM, Nicholson BJ,. 1999. Dissection of the molecular basis of pp60(v-src) induced gating of connexin 43 gap junction channels. J Cell Biol 144: 1033-1045. (Pubitemid 29238976)